Effects of Growth Hormone on Exercise Capacity
NCT00501514 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2009-01-29
Summary
The purpose of this study was to assess whether Growth Hormone(GH)improves exercise capacity and cardiopulmonary performance in patients with chronic heart failure.
Conditions
Interventions
- DRUG
-
Growth hormone
Sponsors & Collaborators
-
Federico II University
lead OTHER
Principal Investigators
-
Luigi Saccà, MD · Federico II University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-11-30
- Completion
- 2005-11-30
Countries
- Italy
Study Locations
More Related Trials
-
Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure
NCT00182169 ·Status: COMPLETED ·Phase: PHASE2
-
Growth Hormone and Heart Failure
NCT00190359 ·Status: TERMINATED
-
Effects of Growth Hormone Supplementation to Adults With Growth Hormone Deficient on Metabolism and Adipose Tissue Molecular Phenotype
NCT01616095 ·Status: COMPLETED
-
Effects of Growth Hormone on the Nitric Oxide Pathway
NCT00470002 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Growth Hormone (GH) on Lipid Depots
NCT00491582 ·Status: COMPLETED ·Phase: NA
-
Treatment of the lOw IGF-1 Syndrome aSsociated With Chronic Heart fAilure: A Randomized, Placebo-Controlled, Double-Blind Study.
NCT01235273 ·Status: SUSPENDED ·Phase: PHASE2
-
Growth Hormone's Effect on the Cardiovascular System
NCT00397319 ·Status: TERMINATED
-
Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors
NCT00684957 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Effect of 5 Years of GH Replacement on Atherosclerosis
NCT00462475 ·Status: COMPLETED
-
Growth Hormone in Ischemic Heart Failure
NCT04420481 ·Status: COMPLETED ·Phase: PHASE3
-
Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy
NCT00711061 ·Status: COMPLETED
-
Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency
NCT00646815 ·Status: COMPLETED ·Phase: NA
-
Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
NCT00552851 ·Status: UNKNOWN ·Phase: PHASE4
-
Cardiovascular Outcome After Surgery or Somatostatin Analogues
NCT00615004 ·Status: COMPLETED
-
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
NCT00182091 ·Status: COMPLETED ·Phase: NA
-
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
NCT00004332 ·Status: COMPLETED
-
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
NCT00488124 ·Status: COMPLETED ·Phase: PHASE2
-
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing
NCT00324064 ·Status: COMPLETED ·Phase: NA
-
The Effect of Growth Hormone Replacement on Liver Fat
NCT00774579 ·Status: COMPLETED
-
Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment
NCT01302652 ·Status: COMPLETED
-
Growth Hormone Signaling in Vivo in Humans
NCT00512473 ·Status: COMPLETED ·Phase: NA
-
Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly
NCT01410799 ·Status: TERMINATED ·Phase: PHASE2
-
Acute Application of Pegvisomant and Octreotide in Acromegaly
NCT00595140 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency
NCT01698944 ·Status: TERMINATED ·Phase: PHASE4
-
Growth Hormone Treatment on Phosphocreatine Recovery in Obesity
NCT01421589 ·Status: COMPLETED ·Phase: NA